SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

New RAMP 201 analyses of Verastems avutometinibdefactinib combination in recurrent low-grade serous ovarian cancer are drawing attention, especially findings in KRAS wild-type patients and comparisons with conventional care that traders say could broaden the treatment opportunity. The community is weighing that potential against a muted share-price reaction, while also watching for the forthcoming VS-7375 clinical update across several cancers.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention over reports that OpenAIs latest Ultrafast model uses Nvidia GPUs rather than Cerebras hardware, raising questions about its key customer relationship; the claims are unconfirmed, and traders debate whether this signals competitive risk or reflects limited Cerebras capacity. Staggered post-IPO share unlocks and insider selling add supply concerns, while bullish traders point to Cerebras broader AI-inference opportunity and partnership prospects.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Evernorths approved business combination and planned Nasdaq listing under XRPN dominate discussion, with traders focused on the companys large XRP treasury. Many are frustrated that XRPN has rallied while XRP remains range-bound, debating whether the treasury vehicle will eventually support the token or simply draw attention and capital away from it.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Anticipation of Anthropics potential IPO and public prospectus filing is driving interest, with traders viewing DXYZ as a way to gain exposure to Anthropic and expecting its private-market valuation to lift the funds NAV. Bullish expectations for a pre-IPO run-up are tempered by debate over filing delays, the reliability of NAV estimates, and whether DXYZs shares will continue trading at a discount.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedixs strong second-quarter results, higher adjusted EBITDA outlook, and newly secured DaVita agreement are driving attention, alongside discussion of DefenCaths rollout across major dialysis providers. Traders are split between optimism about adoption and short-squeeze potential and concern that post-TDAPA reimbursement pressure and limited visibility on future sales could weigh on the shares.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ais quarterly results are driving attention: traders are weighing improved bookings, positive cash flow and narrower losses against sharply lower revenue and a revenue outlook below expectations. The community is split between seeing progress in the turnaround and questioning whether the company can restore growth, with short-squeeze speculation also present.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians record Q3 deliveries beat analyst expectations, but the company reaffirmed rather than raised its full-year guidance, prompting a sell-the-news reaction. Some traders view the R2 ramp and delivery growth positively, while others focus on unprofitability, margins, and execution risks.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

Karman is drawing attention after a steep selloff tied to concerns about valuation, cash generation and its acquisition-funded debt; traders are debating whether the decline is overdone. Some see insider buying and the companys large defense-and-space backlog as reasons for optimism, while skeptics remain focused on cash conversion and valuation.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is drawing attention over changes to its Phase III FLAMINGO-01 trial, including broader enrollment and a higher event threshold for the first interim analysis. Traders debate whether the redesign improves the odds of a meaningful result and pharma interest or mainly delays a catalyst and increases funding risk; partnership talk remains speculation.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A rebound and potential technical breakout have fueled bullish talk, with traders citing COMPs limited token supply, expected DeFi/altcoin momentum, and Compounds institutional push and planned V4 roadmap. Optimists see room to catch up with other DeFi tokens, while skeptics point to weak relative performance and concerns about liquidity and security.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


jnetotod4

Taylor Tina